pharma · Plaque Psoriasis · Moderate-to-Severe Plaque Psoriasis · ORKA
Oruka Therapeutics
Oruka Therapeutics clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Waltham, USA
- Employees
- 78
- Programs
- 6
- Drugs
- 3
- Patents
- 0
Oruka Therapeutics projects
6 ClinicalTrials.gov programs sponsored by Oruka Therapeutics.
Oruka Therapeutics has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ORKA-001
Oruka Therapeutics
Plaque Psoriasis
2 trials -
ORKA-001 Induction Dose
Oruka Therapeutics
Plaque Psoriasis
1 trial -
ORKA-001, Placebo for ORKA-001
Oruka Therapeutics
Moderate-to-Severe Plaque Psoriasis
1 trial -
ORKA-002
Oruka Therapeutics
Plaque Psoriasis
1 trial -
ORKA-001
Oruka Therapeutics
Healthy Volunteers
1 trial -
ORKA-002
Oruka Therapeutics
Healthy Volunteers
1 trial
Frequently asked questions
How many clinical projects does Oruka Therapeutics have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.